Seven million Nigerian girls have been vaccinated against the human papillomavirus (HPV), a critical step in protecting them from cervical cancer later in life, according to Gavi, the vaccine alliance.
Cervical cancer is the second most prevalent cancer among women in Nigeria, claiming countless
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
